官网链接
折扣/货期| 货号：CDX-V0043-M005 | 规格：5 mg | 目录价：￥462 |
| 货号：CDX-V0043-M025 | 规格：25 mg | 目录价：￥1386 |
产品详情
* 以下信息仅供参考，详情请以原厂网站为准
产品名称:
Vandetanib
别名:
N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine; ZD6474; Zactima; CH 331
产品描述:
Vandetanib is an orally available, ATP mimetic small molecule tyrosine kinases inhibitor that targets vascular endothelial growth factor receptor-2 (VEGFR-2), VEGFR-3 and epidermal growth factor receptor (EGFR), REarranged during Transfection (RET) and slightly VEGFR-1. Inhibition of these tyrosine kinases blocks multiple intracellular signaling pathways involved in tumor growth, proliferation, progression and angiogenesis. It inhibits RET, VEGFR2, VEGFR3, VEGFR1, EGFR, PDGFRbeta, Tie-2, and FGFR1 in cell-free assays (IC50s = 34, 40, 110, 1,600, 500, 1,100, 2,500, and 3,600 nM, respectively). It also binds to 142 additional kinases in a panel of 442 kinases (Kds = 4.6-7,900 nM). Vandetanib (1 and 2.5 µM) induces apoptosis, autophagy, ROS and cell cycle arrest at the G0/G1 phase and has anti-proliferative properties in several cancer cell lines and in in vivo cancer models. Formulations containing vandetanib have been used in the treatment of medullary thyroid cancer.
宿主来源:
Synthetic.
保存温度:
+4°C
运输温度:
Ambient
预期分子量:
475.4
产品形式:
solid
产地:
瑞士
纯度:
>98% (NMR)
CAS号:
443913-73-3
分子式:
C22H24BrFN4O2
促销活动
精品推荐
复制QQ号成功，请打开QQ后添加好友进行咨询